U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H22F3N3
Molecular Weight 349.3933
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LY-165163

SMILES

NC1=CC=C(CCN2CCN(CC2)C3=CC(=CC=C3)C(F)(F)F)C=C1

InChI

InChIKey=GAAKALASJNGQKD-UHFFFAOYSA-N
InChI=1S/C19H22F3N3/c20-19(21,22)16-2-1-3-18(14-16)25-12-10-24(11-13-25)9-8-15-4-6-17(23)7-5-15/h1-7,14H,8-13,23H2

HIDE SMILES / InChI

Molecular Formula C19H22F3N3
Molecular Weight 349.3933
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

LY-165163 is a partial agonist of serotonin receptors 5-HT1A and 5-HT1D. It exhibits marked activity at both pre- and postsynaptic dopaminergic D2 (D3 and D1) receptors. LY-165163 caused a significant and dose-dependent hypothermia in rats. As a 5-HT1D receptor agonist, LY-165163 was proposed for the ocular pain treatment.

Originator

Curator's Comment: # Eli Lilly and Co.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Design and synthesis of novel insecticides based on the serotonergic ligand 1-[(4-aminophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]piperazine (PAPP).
2010-03-10
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
1998-08-21
Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
1995-06
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
1993-03
The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
1991-09-16
Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
1986-11
5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity.
1985-04-01
Patents

Sample Use Guides

Rat: 1.25 to 20 mg/kg
Route of Administration: Intraperitoneal
In Vitro Use Guide
With either 10 microM 5-HT or 1 microM 8-hydroxy-2-(di-n-propylamino)tetralin to define nonspecific binding, [3H]PAPP bound to a single class of sites in rat cortical membranes with a KD of 1.6 nM and a maximal binding density (Bmax) of 162 fmol/mg of protein.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:03:34 GMT 2025
Edited
by admin
on Mon Mar 31 19:03:34 GMT 2025
Record UNII
8HAJ699EWG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LY-165163
Common Name English
P-NH2-PE-TFMPP
Preferred Name English
BENZENAMINE, 4-(2-(4-(3-(TRIFLUOROMETHYL)PHENYL)-1-PIPERAZINYL)ETHYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
121930
Created by admin on Mon Mar 31 19:03:34 GMT 2025 , Edited by admin on Mon Mar 31 19:03:34 GMT 2025
PRIMARY
FDA UNII
8HAJ699EWG
Created by admin on Mon Mar 31 19:03:34 GMT 2025 , Edited by admin on Mon Mar 31 19:03:34 GMT 2025
PRIMARY
CAS
1814-64-8
Created by admin on Mon Mar 31 19:03:34 GMT 2025 , Edited by admin on Mon Mar 31 19:03:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID30171136
Created by admin on Mon Mar 31 19:03:34 GMT 2025 , Edited by admin on Mon Mar 31 19:03:34 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY